1. Home
  2. TNON vs CELZ Comparison

TNON vs CELZ Comparison

Compare TNON & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenon Medical Inc.

TNON

Tenon Medical Inc.

HOLD

Current Price

$0.91

Market Cap

4.8M

Sector

Health Care

ML Signal

HOLD

Logo Creative Medical Technology Holdings Inc.

CELZ

Creative Medical Technology Holdings Inc.

HOLD

Current Price

$0.41

Market Cap

4.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNON
CELZ
Founded
2012
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
4.6M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
TNON
CELZ
Price
$0.91
$0.41
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $6.00
N/A
AVG Volume (30 Days)
★ 95.4K
79.0K
Earning Date
11-12-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 84.90
32.08
EPS
N/A
★ N/A
Revenue
★ $3,944,000.00
$6,000.00
Revenue This Year
$44.38
N/A
Revenue Next Year
$39.49
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 20.35
N/A
52 Week Low
$0.96
$0.44
52 Week High
$40.95
$4.72

Technical Indicators

Market Signals
Indicator
TNON
CELZ
Relative Strength Index (RSI) 22.15 22.17
Support Level N/A N/A
Resistance Level $4.18 $2.39
Average True Range (ATR) 0.17 0.05
MACD -0.02 -0.01
Stochastic Oscillator 4.65 0.95

Price Performance

Historical Comparison
TNON
CELZ

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

About CELZ Creative Medical Technology Holdings Inc.

Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.

Share on Social Networks: